NASDAQ:CGC - Canopy Growth Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $22.95
  • Forecasted Upside: 115.66 %
  • Number of Analysts: 17
  • Breakdown:
  • 5 Sell Ratings
  • 10 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.49 (4.83%)

This chart shows the closing price for CGC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Canopy Growth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CGC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CGC

Analyst Price Target is $22.95
▲ +115.66% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Canopy Growth in the last 3 months. The average price target is $22.95, with a high forecast of $55.00 and a low forecast of $8.00. The average price target represents a 115.66% upside from the last price of $10.64.

This chart shows the closing price for CGC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 17 contributing investment analysts is to hold stock in Canopy Growth. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 13 hold ratings
  • 5 sell ratings
  • 1 strong buy ratings
  • 5 buy ratings
  • 10 hold ratings
  • 5 sell ratings
  • 1 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 4 sell ratings
  • 1 strong buy ratings
  • 1 buy ratings
  • 11 hold ratings
  • 5 sell ratings
  • 1 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 4 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 4 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 4 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 10 hold ratings
  • 5 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 10 hold ratings
  • 5 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/6/2021Wells Fargo & CompanyInitiated CoverageUnderweight$8.00N/A
11/30/2021Eight CapitalDowngradeNeutral ➝ SellMedium
11/23/2021Jefferies Financial GroupLower Price TargetPositive ➝ HoldC$25.28 ➝ C$16.70Low
11/18/2021Bank of AmericaLower Price TargetNeutralC$22.00 ➝ C$19.00High
11/18/2021BarclaysInitiated CoverageEqual Weight$14.00High
11/8/2021Canaccord GenuityDowngradeHold ➝ SellHigh
11/8/2021CowenDowngradeOutperform ➝ Market Perform$26.69 ➝ $21.60High
11/8/2021CIBCDowngradeNeutral ➝ UnderperformHigh
11/5/2021Alliance Global PartnersLower Price TargetNeutralC$20.00 ➝ C$18.00Low
10/14/2021Alliance Global PartnersLower Price TargetNeutralC$25.00 ➝ C$20.00Medium
10/1/2021Bank of AmericaDowngradeBuy ➝ NeutralHigh
9/23/2021CIBCLower Price TargetNeutralC$27.00 ➝ C$22.00Low
9/20/2021Cantor FitzgeraldLower Price TargetPositive ➝ NeutralC$30.50 ➝ C$21.00High
9/20/2021Piper SandlerLower Price TargetPositive ➝ Neutral$19.00 ➝ $15.00High
8/11/2021Jefferies Financial GroupUpgradeUnderperform ➝ HoldLow
8/9/2021CIBCLower Price TargetNeutralC$30.00 ➝ C$27.00Medium
8/9/2021Canaccord GenuityBoost Price TargetHoldC$25.00 ➝ C$30.00Low
7/8/2021Piper SandlerLower Price TargetNeutral$27.00 ➝ $24.00Low
6/3/2021DesjardinsLower Price TargetHoldC$55.00 ➝ C$35.00Medium
6/2/2021CIBCLower Price TargetNeutralC$38.00 ➝ C$36.00Medium
6/2/2021Eight CapitalUpgradeSell ➝ NeutralHigh
6/1/2021Canaccord GenuityUpgradeSell ➝ HoldHigh
6/1/2021Alliance Global PartnersReiterated RatingNeutral$40.00 ➝ $32.00High
5/25/2021MKM PartnersUpgradeNeutral ➝ Buy$55.00High
5/11/2021CIBCLower Price TargetNeutral$55.00 ➝ $38.00Low
4/28/2021Bank of AmericaInitiated CoverageBuyHigh
4/9/2021Cantor FitzgeraldLower Price TargetNeutral$62.00 ➝ $35.00Medium
4/8/2021Alliance Global PartnersLower Price TargetUnderperform ➝ Neutral$60.00 ➝ $40.00High
4/5/2021CIBCLower Price TargetNeutral$64.00 ➝ $55.00Low
2/24/2021Jefferies Financial GroupDowngradeHold ➝ UnderperformLow
2/11/2021DesjardinsBoost Price TargetHold$22.00 ➝ $55.00Low
2/10/2021CIBCBoost Price TargetNeutral$32.00 ➝ $64.00Low
2/10/2021CormarkDowngradeMarket Perform ➝ ReduceLow
2/10/2021BMO Capital MarketsReiterated RatingMarket PerformLow
2/10/2021Cantor FitzgeraldBoost Price TargetNeutral$50.00 ➝ $62.00Low
2/10/2021BenchmarkDowngradeBuy ➝ HoldLow
2/10/2021Canaccord GenuityDowngradeHold ➝ Sell$25.00 ➝ $32.00Low
2/5/2021Piper SandlerDowngradeOverweight ➝ Neutral$27.00Medium
2/4/2021Stifel NicolausReiterated RatingBuy$23.00Low
1/5/2021Cantor FitzgeraldBoost Price TargetNeutral$29.00 ➝ $33.00N/A
11/16/2020Jefferies Financial GroupBoost Price TargetHold$16.00 ➝ $21.10Low
11/11/2020CIBCBoost Price TargetNeutral$25.00 ➝ $32.00Low
11/10/2020Canaccord GenuityBoost Price TargetHold$22.00 ➝ $25.00Low
9/4/2020CfraUpgradeBuy ➝ Strong-BuyMedium
8/21/2020OppenheimerReiterated RatingHoldMedium
8/6/2020Canaccord GenuityReiterated RatingHold$21.00High
6/22/2020OppenheimerInitiated CoverageHoldLow
6/1/2020Canaccord GenuityLower Price TargetHold$23.00 ➝ $21.00Low
6/1/2020ScotiabankBoost Price TargetSector Perform$28.00 ➝ $33.00Low
6/1/2020LADENBURG THALM/SH SHDowngradeBuy ➝ NeutralLow
6/1/2020Alliance Global PartnersBoost Price TargetNeutral$24.00 ➝ $30.00Low
6/1/2020Pi FinancialDowngradeNeutral ➝ SellMedium
6/1/2020BMO Capital MarketsDowngradeOutperform ➝ Market PerformHigh
6/1/2020Bryan, Garnier & CoDowngradeNeutral ➝ SellHigh
6/1/2020Stifel NicolausDowngradeBuy ➝ SellHigh
6/1/2020CIBCDowngradeOutperform ➝ NeutralHigh
5/26/2020Pi FinancialReiterated RatingNeutral ➝ NeutralHigh
5/22/2020Bank of AmericaInitiated CoverageBuyHigh
5/14/2020Cantor FitzgeraldLower Price TargetNeutral$27.00 ➝ $25.00Medium
4/17/2020Canaccord GenuityReiterated RatingHold ➝ NeutralMedium
4/16/2020Jefferies Financial GroupUpgradeUnderperform ➝ Hold$17.30 ➝ $15.60High
3/5/2020Laurentian Bank of CanadaUpgradeBuyHigh
2/18/2020CIBCReiterated RatingBuy$35.00Medium
2/18/2020Stifel NicolausBoost Price TargetBuy$30.00 ➝ $35.00Low
2/14/2020Pi FinancialDowngradeHold$30.00N/A
2/5/2020OppenheimerReiterated RatingHoldHigh
1/28/2020Bank of AmericaReiterated RatingBuy$36.00Medium
1/28/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$40.00High
12/12/2019Cantor FitzgeraldBoost Price TargetNeutral$18.90 ➝ $27.00High
12/9/2019Cantor FitzgeraldReiterated RatingHold$14.27Low
12/5/2019MKM PartnersReiterated RatingHold$23.00Low
11/29/2019Eight CapitalDowngradeHold$25.00High
11/27/2019Bank of AmericaUpgradeNeutral ➝ BuyLow
11/20/2019Bank of AmericaUpgradeNeutral ➝ Buy$15.32High
11/15/2019Compass PointLower Price TargetNeutral$24.00 ➝ $17.00Low
11/15/2019Alliance Global PartnersDowngradeBuy ➝ NeutralMedium
11/5/2019Cantor FitzgeraldInitiated CoverageNeutralHigh
10/22/2019Piper Jaffray CompaniesLower Price TargetOverweight$40.00 ➝ $36.00High
10/15/2019MKM PartnersDowngradeSellN/A
10/14/2019Seaport Global SecuritiesDowngradeBuy ➝ NeutralHigh
10/11/2019Jefferies Financial GroupDowngradeHold ➝ Underperform$25.00High
10/1/2019Piper Jaffray CompaniesLower Price TargetOverweight$49.00 ➝ $40.00Low
9/27/2019Bank of AmericaDowngradeBuy ➝ Neutral$27.00Medium
9/19/2019MKM PartnersInitiated CoverageNeutralHigh
9/17/2019OppenheimerInitiated CoverageMarket PerformMedium
8/26/2019Seaport Global SecuritiesUpgradeNeutral ➝ Buy$31.00Low
8/16/2019DesjardinsReiterated RatingHoldMedium
8/16/2019Canaccord GenuityReiterated RatingBuyMedium
8/16/2019Piper Jaffray CompaniesLower Price TargetOverweight$54.00 ➝ $49.00High
8/16/2019BenchmarkLower Price TargetBuy$100.00 ➝ $60.00Low
8/16/2019Stifel NicolausReiterated RatingBuy$50.00 ➝ $44.00Low
7/17/2019LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$50.00Low
7/8/2019Piper Jaffray CompaniesLower Price TargetOverweight$57.00 ➝ $54.00Low
7/5/2019Bryan, Garnier & CoDowngradeBuy ➝ NeutralLow
7/4/2019DesjardinsReiterated RatingHoldLow
7/3/2019Bank of AmericaSet Price TargetBuy$53.00Low
7/3/2019Stifel NicolausReiterated RatingBuyLow
6/28/2019Consumer EdgeInitiated CoverageEqual Weight ➝ Equal WeightLow
6/24/2019DesjardinsReiterated RatingHoldMedium
6/21/2019Piper Jaffray CompaniesSet Price TargetBuy$60.00Medium
6/19/2019Bank of AmericaLower Price TargetBuy$80.00 ➝ $75.00Low
6/12/2019Evercore ISIInitiated CoverageOutperform$120.00 ➝ $107.57Low
6/10/2019Compass PointInitiated CoverageNeutral$43.76Medium
6/7/2019Bank of AmericaSet Price TargetBuy$80.00High
6/5/2019Stifel NicolausInitiated CoverageBuy ➝ Buy$40.83Low
5/13/2019Alliance Global PartnersInitiated CoverageBuyHigh
4/25/2019DesjardinsInitiated CoverageBuy ➝ BuyHigh
4/22/2019GMP SecuritiesUpgradeHold ➝ Buy$65.00 ➝ $72.00High
4/17/2019Bank of AmericaInitiated CoverageBuy ➝ BuyLow
4/12/2019Piper Jaffray CompaniesSet Price TargetBuy$80.00High
4/2/2019Seaport Global SecuritiesReiterated RatingHoldLow
4/2/2019Piper Jaffray CompaniesReiterated RatingBuyLow
2/25/2019Jefferies Financial GroupInitiated CoverageHold ➝ HoldLow
2/21/2019Seaport Global SecuritiesInitiated CoverageNeutral ➝ Neutral$46.27Low
2/19/2019GMP SecuritiesDowngradeBuy ➝ HoldLow
2/15/2019Piper Jaffray CompaniesSet Price TargetBuy$60.00Medium
2/2/2019Piper Jaffray CompaniesSet Price TargetBuy$60.00Medium
1/25/2019Piper Jaffray CompaniesBoost Price TargetOverweight ➝ Overweight$40.00 ➝ $60.00High
1/18/2019CIBCInitiated CoverageSector Outperform ➝ OutperformLow
1/9/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$40.00High
10/17/2018ScotiabankInitiated CoverageHold$61.00Medium
9/25/2018BenchmarkInitiated CoverageBuy ➝ BuyMedium
8/16/2018Canaccord GenuityUpgradeHold ➝ BuyHigh
12/19/2017Canaccord GenuitySet Price TargetHold$19.00N/A
8/14/2017Echelon Wealth PartnersSet Price TargetBuy$11.00Low
4/4/2017Canaccord GenuitySet Price TargetHold$12.00Low
3/22/2017Echelon Wealth PartnersSet Price TargetBuy$14.00High
1/10/2017CowenReiterated RatingOutperformC$13.00N/A
12/12/2016Beacon SecuritiesReiterated RatingBuyN/A
(Data available from 12/7/2016 forward)

News Sentiment Rating

0.82 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 7 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
  • 5 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
  • 9 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
  • 11 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 11 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.


  • No negative mentions tracked during this time.
Canopy Growth logo
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Read More

Today's Range

Now: $10.64
Low: $10.13
High: $10.93

50 Day Range

MA: $12.80
Low: $9.94
High: $15.27

52 Week Range

Now: $10.64
Low: $9.54
High: $56.50


8,779,983 shs

Average Volume

5,092,625 shs

Market Capitalization

$4.19 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Canopy Growth?

The following Wall Street sell-side analysts have issued reports on Canopy Growth in the last year: Alliance Global Partners, Bank of America Co., Barclays PLC, Benchmark Co., BMO Capital Markets, Canaccord Genuity, Cantor Fitzgerald, CIBC, Cormark, Cowen Inc, Desjardins, Eight Capital, Jefferies Financial Group Inc., MKM Partners, Piper Sandler, Stifel Nicolaus, TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for CGC.

What is the current price target for Canopy Growth?

13 Wall Street analysts have set twelve-month price targets for Canopy Growth in the last year. Their average twelve-month price target is $22.95, suggesting a possible upside of 115.7%. MKM Partners has the highest price target set, predicting CGC will reach $55.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $8.00 for Canopy Growth in the next year.
View the latest price targets for CGC.

What is the current consensus analyst rating for Canopy Growth?

Canopy Growth currently has 5 sell ratings, 10 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CGC, but not buy more shares or sell existing shares.
View the latest ratings for CGC.

How do I contact Canopy Growth's investor relations team?

Canopy Growth's physical mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company's listed phone number is (855) 558-9333 and its investor relations email address is [email protected] The official website for Canopy Growth is